Veterinary Medicines

Injectio Glucosi Isotonica et Natrii Chlorati Isotonica 1:1 WET Baxter (25 g + 4,5 g)/1000 ml Roztwór do infuzji

Authorised
  • Glucose
  • Sodium chloride
Download as PDF

Product identification

Medicine name:
Injectio Glucosi Isotonica et Natrii Chlorati Isotonica 1:1 WET Baxter (25 g + 4,5 g)/1000 ml Roztwór do infuzji
Active substance:
  • Glucose
  • Sodium chloride
Target species:
  • Goat
  • Horse
  • Cat
  • Pig
  • Cattle
  • Dog
  • Sheep
Route of administration:
  • Intraperitoneal use
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Glucose
    25.00
    gram(s)
    /
    1000.00
    millilitre(s)
  • Sodium chloride
    4.50
    gram(s)
    /
    1000.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Goat
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Goat
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
  • Intravenous use
    • Goat
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Baxter Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bieffe Medital S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0275
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download